{"id":70664,"date":"2026-05-12T08:56:17","date_gmt":"2026-05-12T08:56:17","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70664"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"mots-c","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/mots-c\/","title":{"rendered":"MOTS-c"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le MOTS-c ?<\/h3>\n<p style=\"margin: 0;\"><strong>MOTS-c<\/strong> (Mitochondrial Open Reading frame of the Twelve S rRNA-c) is a 16-amino-acid mitochondrially-encoded signaling peptide first identified in 2015. In published preclinical studies it acts as an exercise-mimetic and metabolic regulator by activating the AMPK pathway, restoring insulin sensitivity, and modulating nuclear gene expression in response to mitochondrial stress. Supplied in 10\u00a0mg to 40\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1627580-64-6<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>100<\/sub>H<sub>152<\/sub>N<sub>28<\/sub>O<sub>22<\/sub>S<sub>2<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">2174.62 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR, 16 acides amin\u00e9s ; cod\u00e9 dans le g\u00e8ne mitochondrial 12S rRNA)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (blanche \u00e0 blanc cass\u00e9)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le MOTS-c ?<\/h2>\n<p><strong>MOTS-c<\/strong> (Mitochondrial Open Reading frame of the Twelve S rRNA-c) est un peptide de 16 acides amin\u00e9s identifi\u00e9 pour la premi\u00e8re fois par Lee et al. dans <em>Cell Metabolism<\/em> (2015) as a member of the newly recognised class of mitochondrially-derived peptides (MDPs). Unlike every other peptide in the studies catalog \u2014 which are encoded by nuclear DNA and synthesised in the cytoplasm \u2014 MOTS-c is encoded within the mitochondrial 12S rRNA gene and translated by mitochondrial ribosomes. This unusual biological origin makes it a direct intracellular signal of mitochondrial state, and the most-cited member of a peptide class that includes humanin and the SHLP family. The peptide sequence is MRWQEMGYIFYPRKLR, molecular weight approximately 2,175\u00a0Da, empirical formula C<sub>100<\/sub>H<sub>152<\/sub>N<sub>28<\/sub>O<sub>22<\/sub>S<sub>2<\/sub>. Le MOTS-c endog\u00e8ne passe des mitochondries au noyau en cas de stress m\u00e9tabolique et oxydatif, o\u00f9 il r\u00e9gule un programme g\u00e9n\u00e9tique li\u00e9 au cycle des folates et au m\u00e9tabolisme de la m\u00e9thionine \u2014 un m\u00e9canisme sans \u00e9quivalent parmi les peptides cod\u00e9s par le noyau. Le MOTS-c est fourni sous forme de poudre lyophilis\u00e9e de haute puret\u00e9 \u00e0 reconstituer avec de l'eau bact\u00e9riostatique et est <strong>for clinical studies use only<\/strong>. For related metabolic and longevity peptides, see our full <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 AMPK, m\u00e9tabolisme du glucose et translocation nucl\u00e9aire<\/h2>\n<p>Ce qui diff\u00e9rencie MOTS-c des peptides m\u00e9taboliques plus anciens est son <strong>Activation de la voie AMPK<\/strong> that spans the mitochondrion, the cytoplasm, and the nucleus \u2014 each contributing to the observed metabolic phenotype in published studies:<\/p>\n<ul>\n<li><strong>Sensibilit\u00e9 \u00e0 l'insuline et \u00e9limination du glucose<\/strong> \u2014 MOTS-c active la prot\u00e9ine kinase activ\u00e9e par l'AMP (AMPK), le principal capteur \u00e9nerg\u00e9tique cellulaire, en augmentant le rapport AMP:ATP intracellulaire et via un m\u00e9canisme d\u00e9pendant du cycle des folates. L'activation de l'AMPK oriente le m\u00e9tabolisme cellulaire vers le catabolisme : augmentation de l'absorption du glucose via la translocation de GLUT4, oxydation des acides gras, biogen\u00e8se mitochondriale via PGC-1\u03b1 et autophagie. Il s'agit de la m\u00eame voie cibl\u00e9e par la metformine et l'exercice physique, ce qui a valu \u00e0 MOTS-c la description de \u201c peptide mim\u00e9tique de l'exercice \u201d dans la litt\u00e9rature publi\u00e9e.<\/li>\n<li><strong>Translocation nucl\u00e9aire et expression g\u00e9nique adaptative<\/strong> \u2014 In high-fat-diet rodent models, MOTS-c administration restores insulin-stimulated glucose uptake in skeletal muscle and adipose tissue. The effect is independent of body-weight change in some studies designs, suggesting a direct insulin-sensitising mechanism rather than secondary to weight loss. MOTS-c-treated obese mice show normalised oral glucose tolerance and improved euglycaemic-clamp parameters in published studies.<\/li>\n<li><strong>Translocation nucl\u00e9aire et expression g\u00e9nique adaptative<\/strong> \u2014 En situation de stress m\u00e9tabolique ou oxydatif, le MOTS-c se d\u00e9place des mitochondries vers le noyau o\u00f9 il co-r\u00e9gule un programme transcriptionnel centr\u00e9 sur la r\u00e9ponse antioxydante (NRF2), le cycle folate-m\u00e9thionine et les g\u00e8nes m\u00e9taboliques adaptatifs. Cette signalisation r\u00e9trograde mitochondrie-noyau est l'un des premiers exemples au niveau peptidique de communication inter-compartiments intracellulaires et constitue la base des effets plus larges du MOTS-c au-del\u00e0 de l'activation directe de l'AMPK.<\/li>\n<\/ul>\n<p>The biological appeal of MOTS-c in metabolic support is the convergence of these three mechanisms onto pathways already known to mediate the benefits of exercise and caloric restriction. Because endogenous MOTS-c declines markedly with age in human serum (~50% reduction across adult lifespan in published cohorts), the peptide has become a frequent target in aging and longevity studies as well as in metabolic syndrome. <\/p>\n<h2>Published Evidence<\/h2>\n<p>MOTS-c is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Metabolic syndrome and obesity studies<\/strong> \u2014 insulin sensitivity, glucose tolerance, body composition in high-fat-diet rodent models; benchmark peptide for AMPK-axis intervention studies (Lee et al., Cell Metabolism 2015; Reynolds et al., Front Physiol 2021)<\/li>\n<li><strong>Mod\u00e8les pr\u00e9cliniques de diab\u00e8te de type 2<\/strong> \u2014 mod\u00e8les de diab\u00e8te db\/db, ZDF et induits par streptozotocine ; effets sur la sensibilit\u00e9 h\u00e9patique \u00e0 l'insuline, la fonction des cellules b\u00eata et les substituts de l'HbA1c<\/li>\n<li><strong>Capacit\u00e9 d'exercice et biogen\u00e8se mitochondriale<\/strong> \u2014 endurance sur tapis roulant, substituts du VO2max, expression de PGC-1\u03b1, nombre de copies d'ADN mitochondrial dans la recherche sur le muscle squelettique<sub>2<\/sub>max surrogates, PGC-1\u03b1 expression, mitochondrial DNA copy number in skeletal muscle studies<\/li>\n<li><strong>Aging and longevity studies<\/strong> \u2014 lifespan extension models, age-related insulin resistance, sarcopenia; MOTS-c serum levels decline with age, making it a candidate replacement peptide in geroscience studies<\/li>\n<li><strong>Protection cardiovasculaire et r\u00e9nale<\/strong> \u2014 ischaemia-reperfusion injury, oxidative stress markers, mitochondrial dysfunction in cardiac and renal tissue study models<\/li>\n<li><strong>Bone health studies<\/strong> \u2014 diff\u00e9renciation des ost\u00e9oblastes, densit\u00e9 min\u00e9rale osseuse, mod\u00e8les d'ost\u00e9oporose li\u00e9e \u00e0 l'\u00e2ge<\/li>\n<li><strong>Comparative mitochondrial peptide studies<\/strong> \u2014 \u00e9valuation comparative avec d'autres peptides ciblant les mitochondries tels que <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a>. Voir la section de comparaison ci-dessous pour une analyse m\u00e9thodologique c\u00f4te \u00e0 c\u00f4te.<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur la place de MOTS-c dans le paysage des peptides m\u00e9taboliques et de long\u00e9vit\u00e9, voir <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> comme le peptide mitochondrial canonique ciblant la cardiolipine, <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> for telomere\/longevity studies, and <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD+<\/a> for NAD-axis metabolic support. Browse the full <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a> pour les compos\u00e9s associ\u00e9s. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase stocks MOTS-c in three lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, short-cycle protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Flacon de volume interm\u00e9diaire, volume de reconstitution r\u00e9duit par dose<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>40\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle protocols, longevity studies, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials yield greater per-vial dose flexibility and lower per-mg cost; the trade-off is that reconstituted solution must be used within 30 days, so multi-month protocols benefit from larger vials only when the per-week dose is correspondingly high. <\/p>\n<h2>Comparaison \u2014 MOTS-c vs SS-31 (\u00c9lamipr\u00e9tide)<\/h2>\n<p>MOTS-c et <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31<\/a> are the two most-cited mitochondrially-targeted peptides in current studies. They are mechanistically distinct and complementary, not redundant: MOTS-c is a signalling peptide that activates AMPK and nuclear-encoded adaptive programmes, while SS-31 is a structural peptide that binds cardiolipin in the inner mitochondrial membrane to stabilise the electron transport chain. Users often pair them in mitochondrial-dysfunction models for this reason. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">MOTS-c<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">16 acides amin\u00e9s<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 acides amin\u00e9s (t\u00e9trapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Origine<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Encod\u00e9 par l'ADN mitochondrial (g\u00e8ne 12S rRNA)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Peptide synth\u00e9tique Szeto-Schiller<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>M\u00e9canisme principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Activation de l'AMPK, expression des g\u00e8nes nucl\u00e9aires<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Liaison \u00e0 la cardiolipine, stabilisation de la cha\u00eene respiratoire<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Cible cellulaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mitochondrie \u2192 cytoplasme \u2192 noyau<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Membrane mitochondriale interne uniquement<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201315 mg, 1\u20133 fois par semaine<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20135 mg, quotidiennement<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sensibilit\u00e9 \u00e0 l'insuline, capacit\u00e9 d'exercice, vieillissement<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Isch\u00e9mie cardiaque, dysfonction mitochondriale r\u00e9nale<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilement<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frequently co-administered with SS-31 in mitochondrial studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Souvent co-administr\u00e9 avec MOTS-c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The two peptides act on different layers of mitochondrial biology \u2014 MOTS-c regulates metabolic transcription, SS-31 stabilises membrane architecture \u2014 so they address non-overlapping studies questions. For metabolic\/insulin sensitivity, MOTS-c is the default first choice. For cardiac, renal, or ischaemia-reperfusion mitochondrial protection, SS-31 is the canonical comparator. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> Conservez les flacons lyophilis\u00e9s r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine pour le stock de travail \u00e0 court terme. Pour le stockage \u00e0 long terme non ouvert, congelez \u00e0 \u221220 \u00b0C. Le MOTS-c lyophilis\u00e9 est stable sous r\u00e9frig\u00e9ration jusqu'\u00e0 24 mois et \u00e0 \u221220 \u00b0C jusqu'\u00e0 36 mois. \u00c9vitez les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation sur la poudre lyophilis\u00e9e. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon de peptide (pas directement sur le g\u00e2teau lyophilis\u00e9). Pour un flacon de 10 mg, 2,0 mL d'eau bact\u00e9riostatique donnent une concentration de travail de 5 mg\/mL \u2014 10 graduations sur une seringue \u00e0 insuline U-100 \u00e9quivalent \u00e0 500 mcg. Agiter doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> secouer \u2014 et laisser 2 \u00e0 5 minutes pour une dissolution compl\u00e8te. Une solution correctement reconstitu\u00e9e doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Discard any vial showing cloudiness, precipitate, or discolouration. Because MOTS-c is typically dosed 1\u20133 times weekly in protocols, a single reconstituted 10\u00a0mg vial typically supports 2\u20133 weeks of dosing depending on the target dose and frequency. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is MOTS-c used for in studies?<\/h3>\n<p>MOTS-c is used in studies investigating insulin sensitivity, type 2 diabetes models, exercise capacity, mitochondrial biogenesis, aging and longevity, cardiovascular ischaemia-reperfusion injury, renal mitochondrial dysfunction, and bone health. It is the most-cited mitochondrially-encoded signalling peptide in the published literature and serves as a benchmark for AMPK-axis interventions. MOTS-c is <strong>re\u00e7oit pas<\/strong> FDA-approved and is supplied here strictly for clinical studies use only. <\/p>\n<h3>En quoi le MOTS-c diff\u00e8re-t-il du SS-31 (Elamipretide) ?<\/h3>\n<p>MOTS-c is a 16-amino-acid signalling peptide encoded by mitochondrial DNA that activates AMPK and regulates nuclear gene expression. SS-31 is a 4-amino-acid synthetic Szeto-Schiller peptide that binds cardiolipin in the inner mitochondrial membrane to stabilise the electron transport chain. The two address different layers of mitochondrial biology \u2014 MOTS-c at the metabolic-transcription level, SS-31 at the membrane-architecture level \u2014 and are frequently co-administered in mitochondrial-dysfunction studies. <\/p>\n<h3>What is the typical MOTS-c dose?<\/h3>\n<p>Les protocoles pr\u00e9cliniques publi\u00e9s utilisent g\u00e9n\u00e9ralement 5 \u00e0 15 mg par administration dans les mod\u00e8les rongeurs, administr\u00e9s 1 \u00e0 3 fois par semaine pendant des cycles de 4 \u00e0 12 semaines. Un flacon de 10 mg reconstitu\u00e9 avec 2,0 mL d'eau bact\u00e9riostatique donne 5 mg\/mL \u2014 10 crans sur une seringue U-100 \u00e9quivalent \u00e0 500 mcg. <\/p>\n<h3>MOTS-c est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>No. MOTS-c is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>Comment doit-on conserver le MOTS-c ?<\/h3>\n<p>Flacons lyophilis\u00e9s : conserv\u00e9s au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C pour les stocks de travail \u00e0 court terme, ou \u00e0 \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Solution reconstitu\u00e9e : conserv\u00e9e au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation d\u00e9gradent le peptide. Prot\u00e9ger de la lumi\u00e8re directe en permanence. <\/p>\n<h3>Comment reconstituer le MOTS-c ?<\/h3>\n<p>Suivez la proc\u00e9dure de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi du flacon (pas directement sur la poudre lyophilis\u00e9e), agitez doucement et laissez reposer 2 \u00e0 5 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas le flacon. Une solution correctement reconstitu\u00e9e est claire et incolore. Pour un flacon de 10 mg + 2,0 mL de diluant, la concentration de travail est de 5 mg\/mL. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase carries MOTS-c in 10\u00a0mg, 20\u00a0mg, and 40\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Pourquoi appelle-t-on le MOTS-c un peptide \u201c mim\u00e9tique de l'exercice \u201d ?<\/h3>\n<p>The term derives from MOTS-c&#8217;s activation of AMPK and downstream effects on glucose uptake, fatty acid oxidation, and mitochondrial biogenesis \u2014 the same intracellular pathway responsible for many of the metabolic adaptations to exercise. In published studies, MOTS-c administration replicates several phenotypes of exercise training in sedentary animals: improved insulin sensitivity, increased treadmill endurance, and elevated PGC-1\u03b1 expression in skeletal muscle. The metaphor is widely used in geroscience and metabolic-syndrome literature. <\/p>\n<h3>Can MOTS-c and SS-31 be stacked in studies?<\/h3>\n<p>Yes. MOTS-c and SS-31 act on different layers of mitochondrial biology and are frequently co-administered in preclinical mitochondrial-dysfunction studies. MOTS-c regulates metabolic transcription via AMPK; SS-31 stabilises the inner-membrane lipid environment. Their mechanisms are complementary rather than overlapping, which makes the combination useful in study models of multi-axis mitochondrial decline. <\/p>\n<h3>Does MOTS-c cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses in rodent models, with no consistent off-target signals and good tolerability across 4\u201312 week dosing cycles. MOTS-c is structurally an endogenous human peptide, which reduces the risk of antibody-mediated reactions seen with engineered analogs. Long-term human safety data are not available because human trials are still in early stages. <\/p>\n<h3>Quelle est la demi-vie de MOTS-c ?<\/h3>\n<p>In preclinical studies, MOTS-c has an estimated plasma half-life of approximately 3\u20134 hours following subcutaneous administration. The relatively short systemic half-life is offset by intracellular accumulation and the peptide&#8217;s role as an intracellular signalling molecule rather than a circulating hormone \u2014 effects persist beyond the plasma clearance window in study models. <\/p>\n<h3>Pourquoi le MOTS-c endog\u00e8ne diminue-t-il avec l'\u00e2ge ?<\/h3>\n<p>Published cohort data show roughly a 50% decline in human serum MOTS-c levels between young and aged adults. The mechanism is not fully understood but is thought to relate to age-associated mitochondrial DNA mutations, declining mitochondrial transcription, and reduced biosynthesis of mitochondrially-encoded peptides in general. The age-related decline is one reason MOTS-c has attracted strong interest in longevity and geroscience studies. <\/p>\n<h3>How long does MOTS-c take to show effects in preclinical studies?<\/h3>\n<p>Les effets aigus sur la phosphorylation de l'AMPK et l'absorption du glucose sont d\u00e9tectables dans les heures qui suivent l'administration. Les effets sur la sensibilit\u00e9 \u00e0 l'insuline et la composition corporelle dans les mod\u00e8les de rongeurs soumis \u00e0 un r\u00e9gime riche en graisses deviennent g\u00e9n\u00e9ralement statistiquement significatifs apr\u00e8s 2 \u00e0 4 semaines de dosage r\u00e9gulier. Les am\u00e9liorations de la capacit\u00e9 d'exercice (endurance sur tapis roulant, substituts de VO<sub>2<\/sub>max surrogates) accrue over 4\u20138 weeks of continuous dosing. <\/p>\n<h3>Puis-je commander MOTS-c pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die MOTS-c dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 \u00e0 l'exp\u00e9dition de peptides. Les commandes de peptides uniquement sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition de peptides autonome. Toutes les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet et sont couvertes par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\">Politique de R\u00e9exp\u00e9ditions Garanties<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Metabolic, Mitochondrial, and Longevity Studies<\/h2>\n<ul>\n<li><a href=\"\/fr\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 T\u00e9trapeptide mitochondrial liant la cardiolipine \u2014 stabilisateur canonique de la membrane interne<\/li>\n<li><a href=\"\/fr\/nad\/\"><strong>NAD+<\/strong><\/a> \u2014 Nicotinamide adenine dinucleotide \u2014 sirtuin\/longevity-axis metabolic support<\/li>\n<li><a href=\"\/fr\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 telomerase activation and longevity studies<\/li>\n<li><a href=\"\/fr\/semaglutide\/\"><strong>Semaglutide<\/strong><\/a> \u2014 Long-acting GLP-1 agonist \u2014 glycaemic and body-weight studies<\/li>\n<li><a href=\"\/fr\/retatrutide\/\"><strong>Retatrutide<\/strong><\/a> \u2014 Triple GLP-1\/GIP\/glucagon agonist \u2014 multi-axis metabolic support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Comparer les peptides ciblant les mitochondries<\/strong><\/p>\n<p style=\"margin: 0;\">Explorer l'\u00e9ventail <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\"><strong>catalogue de peptides<\/strong><\/a> pour les peptides mitochondriaux et m\u00e9taboliques incluant <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> for cardiolipin-targeted membrane studies, <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD+<\/a> for sirtuin-axis longevity studies, and <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> for telomere-axis longevity studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Peptide de signalisation encod\u00e9 mitochondrialement<br \/>\n\u2705 Active la voie m\u00e9tabolique AMPK<br \/>\n\u2705 Am\u00e9liore la sensibilit\u00e9 \u00e0 l'insuline<br \/>\n\u2705 Mim\u00e9tique de l'exercice dans les mod\u00e8les pr\u00e9cliniques<br \/>\n\u2705 Longevity &amp; geroscience compound<\/p>\n<p><strong>MOTS-c<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70967,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6272,5441],"class_list":["post-70664","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-mots-c","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/70664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=70664"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70967"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=70664"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=70664"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=70664"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=70664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}